Literature DB >> 29484936

The surgical arrest of post-tonsillectomy haemorrhage: Hospital Episode Statistics 12 years on.

M S Osborne1, Mpa Clark2.   

Abstract

Introduction The risk of returning to theatre for arrest of haemorrhage following tonsillectomy can be determined from analysis of the Hospital Episode Statistics data provided by the Department of Health website. This method was employed previously for data between 1998-2002 and was repeated in this study to observe any changes over this time period. Materials and methods Hospital Episode Statistics data for England from 2010-2016 were used. The number of tonsillectomies and surgical arrest of post-tonsillectomy haemorrhage were considered for children and adults. Results Of 267,159 tonsillectomies performed over the six-year period, 5027 (1.88%) returned to theatre for control of bleeding. This was 3.5 times more likely in adults than children (P < 0.0001). Comparison with the previous study showed an increase in return to theatre rates following tonsillectomy of 1.06%, from 0.82% to 1.88%. Conclusion Adults are more likely than children to require and arrest of haemorrhage post-tonsillectomy. Return to theatre rates have increased since 2004 at an estimated additional cost to NHS England of £1,415,056 per annum. The causes of this observed increase have yet to be determined.

Entities:  

Keywords:  Consent; Tonsillectomy

Mesh:

Year:  2018        PMID: 29484936      PMCID: PMC5956599          DOI: 10.1308/rcsann.2018.0034

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  1 in total

1.  The surgical arrest of post-tonsillectomy haemorrhage: hospital episode statistics.

Authors:  M P A Clark; A Waddell
Journal:  Ann R Coll Surg Engl       Date:  2004-11       Impact factor: 1.891

  1 in total
  1 in total

1.  Primary and secondary postoperative hemorrhage in pediatric tonsillectomy.

Authors:  Bin Xu; Hai-Yan Jin; Ke Wu; Cao Chen; Li Li; Yang Zhang; Wei-Zhong Gu; Chao Chen
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.